November 11, 2011 — Maquet Cardiovascular announced U.S. Food and Drug Administration (FDA) 510(k) clearance and CE mark ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
November 7, 2011 — The American College of Cardiology Foundation (ACCF), American Heart Association (AHA), and Society ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
November 7, 2011 — The Million Hearts initiative has announced new partners and commitments, including tools to reach ...
November 4, 2011—Miracor Medical Systems GmbH announced that data will be reported during next week’s Transcatheter ...
November 4, 2011 – W. L. Gore & Associates announced that Royal Sussex County Hospital in Brighton, United Kingdom, is ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
November 4, 2011 — Medtronic Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant ...
November 2, 2011 - The U.S. Food and Drug Administration (FDA) today approved the first transcatheter aortic heart valve ...
November 1, 2011 – The Angiographic and Imaging Core Laboratories of the Clinical Trials Center (CTC) at the ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 1, 2011 – Corindus Vascular Robotics said leading experts in interventional cardiology will speak about their ...
October 31, 2011 — American College of Cardiology (ACC) President David Holmes, M.D., FACC, commended a congressional ...
October 31, 2011 — A panel presentation at the American College of Surgeons' annual clinical congress detailed how the ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 26, 2011 — Medtronic Inc. announced the start of SYMPLICITY HTN-3, the company’s United States clinical trial of ...
October 26, 2011 – St. Jude Medical announced it has received U.S. Food and Drug Administration (FDA) clearance for its ...
October 24, 2011 — New study results reveal several underlying causes of non-ischemic sudden cardiac death (SCD) — those ...
November 11, 2011